AzTrials
AzTrials

Neuromuscular FunctionREBCORENCT07077993

"Muscle Strength, Balance, and Core Endurance in Elite Adolescent Rowers: A Cross-Sectional Study"

An observational study of Neuromuscular Function and Postural Balance, run by Eastern Mediterranean University at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the relationship between lower extremity isokinetic strength, dynamic balance, and core muscle endurance in elite adolescent rowers aged 16-18. A total of 68 athletes (32 males, 36 females) will be assessed through standardized protocols involving isokinetic testing, the Y Balance Test… Read more about this study

Who is it for?
Ages 16 to 18 yearsHealthy volunteers can take part
How many people
68 participants
Where
1 siteCyprus
Study dates
1 Jun 2025to 31 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: The study population consists of 68 elite adolescent rowers (32 females, 36 males) aged 16 to 18 years, actively competing and training under the Turkish Rowing Federation. All participants were healthy, licensed athletes with at least two years of regular rowing experience and were training at least five times per week at a national-level rowing training center.

Who may be able to join

  • Elite adolescent rowers aged 16 to 18 years
  • Licensed athletes training at least 5 days per week
  • Registered with a national-level rowing team or rowing education program
  • Minimum 2 years of regular rowing experience
  • No current musculoskeletal or neurological injury
  • Voluntary participation with informed consent (parental consent required for minors)

Who cannot join

  • History of lower extremity or spinal surgery
  • Current injury or condition affecting strength, balance, or posture
  • Diagnosed neurological disorder or vestibular dysfunction
  • Acute illness, severe fatigue, or muscle soreness on the day of testing
  • Active menstruation phase in female participants on the day of testing
  • Lack of cooperation or unwillingness to follow instructions

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Burcin Ugur Tosun

    Famagusta, 99010

Other trials in Cyprus

About this study

Official title: The Relationship Between Lower Extremity Strength, Dynamic Balance, and Core Endurance in Elite Youth Rowers: A Cross-Sectional Observational Study

This study aims to investigate the relationship between lower extremity isokinetic strength, dynamic balance, and core muscle endurance in elite adolescent rowers aged 16-18. A total of 68 athletes (32 males, 36 females) will be assessed through standardized protocols involving isokinetic testing, the Y Balance Test, and McGill Core Endurance Tests. The study aims to contribute to performance monitoring and injury prevention strategies in rowing sports.

Read the detailed description

This observational cross-sectional study aims to investigate the relationships between lower extremity muscle strength, dynamic balance, and core endurance in elite adolescent rowers aged 16-18. A total of 68 rowers (32 females, 36 males) licensed by the Turkish Rowing Federation were included. All participants had a minimum of two years of rowing experience and trained at least four days per week.

Lower extremity muscle strength was assessed using isokinetic dynamometry at angular velocities of 60°/s and 300°/s. Core endurance was evaluated using the McGill Core Endurance Test Battery, including trunk flexor, extensor, and lateral plank tests. Dynamic balance was assessed via the Y Balance Test and normalized to leg length.

The study also examined potential sex-based differences in neuromuscular performance and investigated inter-variable correlations among muscle strength, balance, and core endurance. In addition, asymmetry in dynamic balance performance was analyzed as a risk factor for performance and injury.

This study is expected to provide practical insights for sports physiotherapists and coaches working with adolescent rowers, particularly in optimizing performance and designing sex-specific injury prevention strategies.

Keywords
Rowing Performance, Core Endurance, Dynamic Balance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07077993
Study groupRoleWhat they receive
Male AthletesElite male adolescent rowers (n=36), aged 16-18, participating in national-level rowing training at least 5 times per week.
Female AthletesElite female adolescent rowers (n=32), aged 16-18, participating in national-level rowing training at least 5 times per week.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Composite Y Balance Test Score (%)

    Dynamic balance will be assessed using the Y Balance Test. Reach distances in three directions will be normalized to limb length, and a composite balance score will be calculated. The outcome will be used to compare balance performance across sex groups.

    Measured: Cross-sectional assessment at baseline (single visit)

  2. Isokinetic Quadriceps Peak Torque at 60°/s (Nm)

    Peak torque of the dominant quadriceps muscle will be measured using an isokinetic dynamometer at an angular velocity of 60°/s. The outcome will be recorded in Newton-meters (Nm) and used to analyze muscle strength differences between groups.

    Measured: Cross-sectional assessment at baseline (single visit)

  3. Core Extensor Endurance Time (seconds)

    Trunk extensor endurance will be evaluated using the McGill Trunk Extensor Endurance Test. Participants will maintain a horizontal prone posture over the edge of a bench with the pelvis stabilized. The maximum time (in seconds) that the position can be held with proper form will be recorded as the endurance score.

    Measured: Cross-sectional assessment at baseline (single visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2025
  2. Study start1 Jun 2025
  3. Primary completion20 Jul 2025
  4. Study completion31 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07077993
Sponsor's protocol ID
2025-06
Acronym
REBCORE
Status last verified
Jul 2026
First submitted
12 Jul 2025
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neuromuscular Function and Postural Balance, run by Eastern Mediterranean University at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Composite Y Balance Test Score (%) (time frame: Cross-sectional assessment at baseline (single visit)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in